Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2101829-58-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal CCDC5 Antibody [DyLight 650]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS1427467 Inquire
Recombinant Arabidopsis thaliana Probable poly (ADP-ribose) glycohydrolase 2 (PARG2) , partial
Ask
View Details 
